Table 1:
Baseline Characteristics | BASILICA (n=16) | LAMPOON (n=4) |
---|---|---|
Demographic Data | ||
| ||
Age | 77.2 ± 8.1 | 75.7 ± 11.8 |
| ||
Female | 11 (69%) | 3 (75%) |
| ||
BSA | 1.9 ± 0.3 | 1.8 ± 0.3 |
| ||
Home oxygen | 4 (25%) | 1 (25%) |
Dialysis | 2 (13%) | 2 (50%) |
| ||
Diabetes mellitus | 7 (44%) | 1 (25%) |
| ||
Atrial fibrillation | 10 (63%) | 2 (50%) |
| ||
Coronary artery disease | 5 (31%) | 0 |
| ||
Peripheral artery disease | 4 (21%) | 0 |
Prior stroke or TIA | 6 (38%) | 1 (25%) |
| ||
Prior aortic valve replacement | 16 (100%) | 3 (75%) |
| ||
NYHA Class III or IV symptoms | 16(100%) | 4 (100%) |
| ||
STS predicted risk of mortality, % | 8.3 ± 4.9 | 17.3 ± 18.3 |
| ||
Echocardiographic Data | ||
| ||
Ejection Fraction | 55% ± 8.8 | 56% ± 8.5 |
| ||
AVA, cm2 | 0.94 ± 0.6 | - |
| ||
AV mean gradient, mmHg | 40 ± 17.7 | - |
| ||
AV peak velocity, m/s | 4.0 ± 1.0 | - |
| ||
MV mean gradient, mmHg | - | 12 ± 5.3 |
| ||
MR severity ≥ moderate | - | 3 (75%) |
| ||
LVOT gradient, mmHg | - | 5.3 ± 2.1 |
AV – aortic valve, AVA – aortic valve area, BSA – body surface area, LVOT – left ventricular outflow tract, MV – mitral valve, NYHA – New York Heart Association, STS – Society of Thoracic Surgeons, TIA – transient ischemic attack